Understand the Science
Tesamorelin/Ipamorelin is a synergistic peptide combination designed to stimulate natural growth hormone production.
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that signals the pituitary gland to increase HGH production, while Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates growth hormone release without significantly impacting cortisol or prolactin levels.
Together, they work to enhance physiologic growth hormone output in a balanced, controlled manner.
Originally, Tesamorelin was FDA-approved for HIV-related fat redistribution. Today, this combination therapy is increasingly used to support fat loss, metabolic function, muscle preservation, and overall vitality in aging adults.
Benefits of Tesamorelin/Ipamorelin:
Stimulates natural HGH production Supports reduction of abdominal and visceral fat Promotes lean muscle preservation and body composition improvements Supports metabolic health and recovery May enhance energy, sleep quality, and overall wellness Utilized in clinical settings with ongoing research support
Common Side effects
Injection site irritation
Mild water retention
Headache
Flushing
Temporary changes in appetite
Strength: 1mg/0.5mg/ml — 6ml vial (1-month supply)
Application: Inject as prescribed by your healthcare provider [How to Inject]
Dosing: Adjusted to individual medical needs
Monitoring: Prescriber consultation required; must be medically appropriate
Tesamorelin/Ipamorelin is a highly targeted therapy, particularly effective for patients with fat redistribution concerns or metabolic health goals.